{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:28:31Z","timestamp":1793053711688,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41391-025-00987-4","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:08:49Z","timestamp":1748830129000},"page":"111-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9523-3400","authenticated-orcid":false,"given":"Leonardo","family":"Quarta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-6876","authenticated-orcid":false,"given":"Francesco","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-2306","authenticated-orcid":false,"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Cannoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zaurito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Viti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-3217","authenticated-orcid":false,"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Leni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nocera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767\u201377.","journal-title":"N Engl J Med"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med. 2020;382:917\u201328.","journal-title":"N Engl J Med"},{"key":"987_CR3","doi-asserted-by":"crossref","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17:41\u201361.","DOI":"10.1038\/s41585-019-0212-4"},{"key":"987_CR4","doi-asserted-by":"crossref","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024;86:148\u201363.","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"987_CR5","doi-asserted-by":"crossref","unstructured":"Pellegrino F, Stabile A, Sorce G, Mazzone E, Cannoletta D, Cirulli GO, et al. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer. Prostate. 2024;84:473\u20138.","DOI":"10.1002\/pros.24665"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","volume":"4","author":"E Mazzone","year":"2021","unstructured":"Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, et al. Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol. 2021;4:697\u2013713.","journal-title":"Eur Urol Oncol"},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.euf.2022.10.002","volume":"9","author":"F Pellegrino","year":"2023","unstructured":"Pellegrino F, Tin AL, Martini A, Vertosick EA, Porwal SP, Stabile A, et al. Prostate-specific antigen density cutoff of 0.15 ng\/ml\/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: efficient threshold or legacy of the past?. Eur Urol Focus. 2023;9:291\u20137.","journal-title":"Eur Urol Focus"},{"key":"987_CR8","doi-asserted-by":"crossref","unstructured":"Benson MC, Whang S, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147:815\u20136.","DOI":"10.1016\/S0022-5347(17)37393-7"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","volume":"198","author":"FA Distler","year":"2017","unstructured":"Distler FA, Radtke JP, Bonekamp D, Kesch C, Schlemmer HP, Wieczorek K, et al. The value of PSA density in combination with PI-RADSTM for the accuracy of prostate cancer prediction. J Urol. 2017;198:575\u201382.","journal-title":"J Urol"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.juro.2018.08.046","volume":"201","author":"M Oishi","year":"2019","unstructured":"Oishi M, Shin T, Ohe C, Nassiri N, Palmer SL, Aron M, et al. Which patients with negative magnetic resonance imaging can safely avoid biopsy for prostate cancer?. J Urol. 2019;201:268\u201376.","journal-title":"J Urol"},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bju.15277","volume":"127","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021;127:175\u20138.","journal-title":"BJU Int"},{"key":"987_CR12","doi-asserted-by":"crossref","unstructured":"Pellegrino F, Stabile A, Sorce G, Quarta L, Robesti D, Cannoletta D, et al. Added value of prostate-specific antigen density in selecting prostate biopsy candidates among men with elevated prostate-specific antigen and PI-RADS \u22653 lesions on multiparametric magnetic resonance imaging of the prostate: a systematic assessment by PI-RADS score. Eur Urol Focus. 2024;10:634\u201340.","DOI":"10.1016\/j.euf.2023.10.006"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.euf.2019.11.012","volume":"7","author":"M G\u00f6rtz","year":"2021","unstructured":"G\u00f6rtz M, Radtke JP, Hatiboglu G, Sch\u00fctz V, Tosev G, G\u00fcttlein M, et al. The value of prostate-specific antigen density for prostate imaging-reporting and data system 3 lesions on multiparametric magnetic resonance imaging: a strategy to avoid unnecessary prostate biopsies. Eur Urol Focus. 2021;7:325\u201331.","journal-title":"Eur Urol Focus"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bju.13465","volume":"119","author":"S Washino","year":"2017","unstructured":"Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, et al. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients. BJU Int. 2017;119:225\u201333.","journal-title":"BJU Int"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00345-022-04118-9","volume":"40","author":"MA Rodr\u00edguez Cabello","year":"2022","unstructured":"Rodr\u00edguez Cabello MA, M\u00e9ndez Rubio S, Platas Sancho A, Carballido Rodr\u00edguez J. Diagnostic evaluation and incorporation of PSA density and the prostate imaging and data reporting system (PIRADS) version 2 classification in risk-nomograms for prostate cancer. World J Urol. 2022;40:2439\u201350.","journal-title":"World J Urol"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.eururo.2022.07.022","volume":"82","author":"M Peters","year":"2022","unstructured":"Peters M, Eldred-Evans D, Kurver P, Falagario UG, Connor MJ, Shah TT, et al. Predicting the need for biopsy to detect clinically significant prostate cancer in patients with a magnetic resonance imaging\u2013detected prostate imaging reporting and data system\/likert \u22653 lesion: development and multinational external validation of the imperial rapid access to prostate imaging and diagnosis risk score. Eur Urol. 2022;82:559\u201368.","journal-title":"Eur Urol"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/pros.24302","volume":"82","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Liang Z, Zuo Y, Zhou Y, Yan W, Wu X, et al. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region. Prostate. 2022;82:556\u201365.","journal-title":"Prostate"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radio. 2012;22:746\u201357.","journal-title":"Eur Radio"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol. 2016;69:16\u201340.","journal-title":"Eur Urol"},{"key":"987_CR20","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76:340\u2013351.","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"987_CR21","doi-asserted-by":"crossref","unstructured":"Sorce G, Stabile A, Lucian\u00f2 R, Motterle G, Scuderi S, Barletta F, et al. Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions. BJU Int. 2022;129:201\u20137.","DOI":"10.1111\/bju.15498"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/pros.24368","volume":"82","author":"F Pellegrino","year":"2022","unstructured":"Pellegrino F, Stabile A, Mazzone E, Sorce G, Barletta F, De Angelis M, et al. Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series. Prostate. 2022;82:1170\u20135.","journal-title":"Prostate"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41391-021-00371-y","volume":"24","author":"A Stabile","year":"2021","unstructured":"Stabile A, Barletta F, Motterle G, Pellegrino F, Sorce G, Mazzone E, et al. Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series. Prostate Cancer Prostatic Dis. 2021;24:1137\u201342.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"987_CR24","doi-asserted-by":"crossref","unstructured":"Barletta F, Stabile A, Mazzone E, Brembilla G, Sorce G, Pellegrino F, et al. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series. Urol Oncol. 2022;40:103.e17\u201324.","DOI":"10.1016\/j.urolonc.2021.09.015"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. 2016;69:428\u201335.","journal-title":"Eur Urol"},{"key":"987_CR26","doi-asserted-by":"crossref","unstructured":"Magi-Galluzzi C, Montironi R, Epstein JI. Contemporary Gleason grading and novel Grade Groups in clinical practice. Vol. 26, Current Opinion in Urology. Lippincott Williams and Wilkins; 2016. p. 488\u201392.","DOI":"10.1097\/MOU.0000000000000320"},{"key":"987_CR27","doi-asserted-by":"crossref","unstructured":"Hamm CA, Baumg\u00e4rtner GL, Padhani AR, Frob\u00f6se KP, Dr\u00e4ger F, Beetz NL, et al. Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies. Eur Radiol. 2024;34:6229\u201340.","DOI":"10.1007\/s00330-024-10700-z"},{"key":"987_CR28","doi-asserted-by":"crossref","unstructured":"Kuanar S, Cai J, Nakai H, Nagayama H, Takahashi H, LeGout J, et al. Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer. Abdom Radiol (NY). 2024;49:3722\u201334.","DOI":"10.1007\/s00261-024-04301-z"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11255-021-03071-7","volume":"54","author":"C Gaudiano","year":"2022","unstructured":"Gaudiano C, Bianchi L, Corcioni B, Giunchi F, Schiavina R, Ciccarese F, et al. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones. Int Urol Nephrol. 2022;54:263\u201371.","journal-title":"Int Urol Nephrol"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clgc.2020.12.007","volume":"19","author":"Y Chen","year":"2021","unstructured":"Chen Y, Ruan M, Zhou B, Hu X, Wang H, Liu H, et al. Cutoff Values of Prostate Imaging Reporting and Data System Version 2.1 Score in Men With Prostate-specific Antigen Level 4 to 10 ng\/mL: Importance of Lesion Location. Clin Genitourin Cancer. 2021;19:288\u201395.","journal-title":"Clin Genitourin Cancer"},{"key":"987_CR31","doi-asserted-by":"crossref","unstructured":"Mjaess G, Haddad L, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, et al. Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions. Prostate Cancer Prostatic Dis. 2025;28:173\u2013179.","DOI":"10.1038\/s41391-024-00872-6"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00987-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:04:34Z","timestamp":1771272274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00987-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-00987-4","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of IRCCS San Raffaele Hospital, Milan, Italy. Because this is a retrospective study, there is no approval number for each study. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}